Tech Company Financing Transactions
RxCell Funding Round
RxCell, based in Singapore, Central Region, received $4.6 million in funding from DMR Global Venture and Regenosis.
Transaction Overview
Company Name
Announced On
12/6/2023
Transaction Type
Venture Equity
Amount
$4,600,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to secure the necessary resources, propelling its promising IND (Investigational New Drug) application testing and process.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Singapore, Central Region, Undisclosed
SG
Singapore, Central Region, Undisclosed
SG
Phone
Undisclosed
Website
Email Address
Overview
RxCell is a biotechnology company focused on therapeutic applications of induced pluripotent stem cells (iPSC).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Xianmin Zeng
Browse more venture capital transactions:
Prev: 12/6/2023: VAST Data venture capital transaction
Next: 12/6/2023: Farmless venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs